Blackhawk Capital Partners LLC Trims Holdings in UnitedHealth Group Incorporated $UNH

Blackhawk Capital Partners LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 38.3% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 1,970 shares of the healthcare conglomerate’s stock after selling 1,221 shares during the period. Blackhawk Capital Partners LLC’s holdings in UnitedHealth Group were worth $533,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Nordea Investment Management AB increased its holdings in UnitedHealth Group by 4.2% in the fourth quarter. Nordea Investment Management AB now owns 91,496 shares of the healthcare conglomerate’s stock valued at $30,287,000 after buying an additional 3,720 shares during the last quarter. Vaughan David Investments LLC IL boosted its position in shares of UnitedHealth Group by 2.7% during the 4th quarter. Vaughan David Investments LLC IL now owns 150,773 shares of the healthcare conglomerate’s stock worth $49,772,000 after acquiring an additional 3,934 shares in the last quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. raised its position in shares of UnitedHealth Group by 1,287.2% during the 1st quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. now owns 60,022 shares of the healthcare conglomerate’s stock worth $16,241,000 after acquiring an additional 55,695 shares in the last quarter. Kensington Investment Counsel LLC acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at $2,888,000. Finally, J. Safra Sarasin Holding AG raised its stake in UnitedHealth Group by 127.6% during the 4th quarter. J. Safra Sarasin Holding AG now owns 34,947 shares of the healthcare conglomerate’s stock worth $11,536,000 after acquiring an additional 19,591 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 800 shares of the firm’s stock in a transaction dated Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the sale, the chief executive officer owned 17,805 shares in the company, valued at $6,320,775. This trade represents a 4.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.28% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts have commented on UNH shares. Argus raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 price target on the stock in a research report on Wednesday, April 22nd. JPMorgan Chase & Co. lifted their target price on shares of UnitedHealth Group from $420.00 to $466.00 and gave the company an “overweight” rating in a report on Monday, June 8th. Royal Bank Of Canada increased their price target on shares of UnitedHealth Group from $400.00 to $463.00 and gave the stock an “outperform” rating in a research note on Thursday, July 9th. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday, June 23rd. Finally, Jefferies Financial Group boosted their price target on UnitedHealth Group from $340.00 to $373.00 and gave the company a “buy” rating in a research report on Monday, April 20th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $429.50.

Read Our Latest Stock Analysis on UNH

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

UnitedHealth Group Stock Down 1.8%

UNH stock opened at $417.33 on Thursday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $434.30. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.80 and a current ratio of 0.80. The company has a fifty day moving average of $402.80 and a 200-day moving average of $341.04. The stock has a market capitalization of $378.99 billion, a PE ratio of 31.52, a price-to-earnings-growth ratio of 1.70 and a beta of 0.62.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The firm had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. During the same quarter last year, the firm earned $7.20 earnings per share. The firm’s revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 18.39 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were given a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a dividend yield of 2.2%. The ex-dividend date was Monday, June 15th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s payout ratio is presently 70.09%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.